We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lonza Facility in Maryland Rapped for CAPAs, Complaints
Lonza Facility in Maryland Rapped for CAPAs, Complaints
The FDA has issued a Form 483 to medical device and biologics manufacturer Lonza based on an inspection last November of the company’s facility in Walkersville, Md.
